Order Article Reprints
Journal: Cancers, 2025
Volume: 17
Number: 437
Article:
Tazemetostat, a Selective EZH2 Inhibitor, in Combination with Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 1 Trial
Authors:
by
Peter J. Oppelt, Sidharth V. Puram, Jingxia Liu, Jessica C. Ley and Douglas Adkins
Link:
https://www.mdpi.com/2072-6694/17/3/437
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.